Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
GLP1R (glucagon-like-peptide-1 incretin receptor), diabetes and obesity phenotypes: An in silico approach revealed new pathogenic variants
SGLT2 inhibitors could block the reabsorption of glucose in the kidneys, leading to increased glucose excretion and improved glycemic control in type 2 diabetes
Moreover, as only abundance data for which both SEM and CON groups exhibited normal distributions is appropriate for parametric analysis, Shapiro-Wilk testing was used to remove all proteins for which data distributions were non-normal in either group
Pediatr Nephrol 27:21232127
US$ 25.97
US$ 21.75
US$ 26.37
US$ 23.86
:max_bytes(150000):strip_icc()/VWH-GettyImages-2178836417-ee318a41780b44e9af3ff47de83fafd7.jpg)
US$ 22.24
